Pulse Biosciences (NASDAQ:PLSE – Get Free Report) will release its earnings data after the market closes on Tuesday, May 7th. Individual interested in listening to the company’s earnings conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($0.21) earnings per share (EPS) for the quarter.
Pulse Biosciences Stock Performance
Shares of Pulse Biosciences stock opened at $7.82 on Monday. The company has a fifty day simple moving average of $8.53 and a 200-day simple moving average of $8.35. Pulse Biosciences has a 12-month low of $3.78 and a 12-month high of $13.62.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Coca-Cola Stock Analysis: Key Insights and Trends
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Metal Stocks Setting Up for Double-Digit Growth
- The How and Why of Investing in Biotech Stocks
- Brinker International Heats Up on Spicy Earnings Beat and Raise
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
